UK Life Sciences Package Includes "Innovation Pass" To Skirt NICE
Executive Summary
LONDON - The UK 's Life Sciences Blueprint is an urgent bid to kick-start a sector that's increasingly important to the nation's future growth - especially in the light of the downturn in financial services
You may also be interested in...
NICE Rejects Vidaza, But Celgene Plans Comparator-Based Appeal
Cancer drug is effective but still too expensive even with a 7 percent price cut, NICE concludes.
NICE Rejects Vidaza, But Celgene Plans Comparator-Based Appeal
Cancer drug is effective but still too expensive even with a 7 percent price cut, NICE concludes.
UK Government Help For Life Sciences Sector Is Welcomed, But Still Not Enough
Therapeutic "clusters" are the next big idea, but unlikely to overshadow industry-academia tie-ups.